FDA Approves Johnson & Johnson’s Ketamine-Derived Drug For Treatment-Resistant Depression - Forbes https://t.co/oeTWcQfU4A
— IDRO (@IDROOhio) March 8, 2019
from Twitter https://twitter.com/IDROOhio
March 07, 2019 at 10:32PM
Friday, March 8, 2019
FDA Approves Johnson & Johnson’s Ketamine-Derived Drug For Treatment-Resistant Depression - Forbes https://t.co/oeTWcQfU4A
from Twitter https://twitter.com/IDROOhio
March 07, 2019 at 10:32PM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment